NDA 12383, held by Merck. Colchicine; Probenecid.
As of Nov 13, 2026, NDA 12383 (Colbenemid), held by Merck, was first approved by FDA on Jul 27, 1961, with 13 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 27, 1961 | Original applicationNew combination · Standard review | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Colbenemid0.5MG;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · tablet;oral | Colchicine; Probenecid | DiscontinuedReference drug |
| Aug 18, 1994 | Supplement 28Manufacturing · Standard review | Approved | None posted |
| Apr 20, 1994 | Supplement 27Manufacturing · Standard review | Approved | None posted |
| Nov 30, 1989 | Supplement 26Manufacturing · Standard review | Approved | None posted |
| May 12, 1988 | Supplement 24Labeling · Standard review | Approved | None posted |
| May 12, 1988 | Supplement 23Labeling · Standard review | Approved | None posted |
| May 12, 1988 | Supplement 21Labeling · Standard review | Approved | None posted |
| Jul 23, 1985 | Supplement 18Manufacturing · Standard review | Approved | None posted |
| Mar 2, 1982 | Supplement 20Manufacturing · Standard review | Approved | None posted |
| Aug 21, 1981 | Supplement 14Labeling · Standard review | Approved | None posted |
| Aug 24, 1979 | Supplement 16Labeling · Standard review | Approved | None posted |
| May 30, 1979 | Supplement 12Manufacturing · Standard review | Approved | None posted |
| May 10, 1979 | Supplement 15Manufacturing · Standard review | Approved | None posted |
| Jun 1, 1978 | Supplement 13Labeling · Standard review | Approved | None posted |
| Jul 27, 1961 | Original applicationNew combination · Standard review | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters